Renalytix Other Stockholder Equity vs Cash And Short Term Investments Analysis

RNLX Stock

USD 0.14 0.01 7.69%

Renalytix financial indicator trend analysis is much more than just breaking down Renalytix AI prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Renalytix AI is a good investment. Please check the relationship between Renalytix Other Stockholder Equity and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Other Stockholder Equity vs Cash And Short Term Investments

Other Stockholder Equity vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Renalytix AI Other Stockholder Equity account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.

The correlation between Renalytix's Other Stockholder Equity and Cash And Short Term Investments is 0.62. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Renalytix AI, assuming nothing else is changed. The correlation between historical values of Renalytix's Other Stockholder Equity and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Renalytix AI are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Stockholder Equity i.e., Renalytix's Other Stockholder Equity and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.62

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Other Stockholder Equity

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Renalytix AI balance sheet. This account contains Renalytix investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Renalytix AI fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Renalytix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Renalytix's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 21.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 18.7 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	58.3M	43.1M	29.0M	33.2M
Cost Of Revenue	2.1M	2.7M	2.1M	1.4M

Total Operating Expenses Cost Of Revenue

Renalytix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Other Current Liab	Property Plant And Equipment Net	Accounts Payable	Non Currrent Assets Other	Short Term Investments
Total Assets		0.34	0.56	0.96	0.94	-0.96	0.04	0.98	0.98	0.77	0.7	0.15	0.4	0.59	0.51	0.88	0.18	0.98	0.91	0.3	0.43	0.64	0.89	0.53	-0.06	0.83
Short Long Term Debt Total	0.34		0.93	0.09	0.17	-0.14	-0.7	0.38	0.35	0.69	0.67	0.68	0.99	0.85	0.96	0.49	0.92	0.37	0.37	0.99	0.75	0.67	0.5	0.77	0.73	0.05
Total Current Liabilities	0.56	0.93		0.32	0.42	-0.37	-0.68	0.58	0.56	0.86	0.81	0.72	0.92	0.95	0.99	0.71	0.87	0.58	0.59	0.93	0.86	0.75	0.58	0.87	0.59	0.33
Total Stockholder Equity	0.96	0.09	0.32		0.95	-0.98	0.27	0.93	0.94	0.61	0.54	-0.04	0.15	0.37	0.27	0.78	-0.08	0.94	0.85	0.04	0.23	0.5	0.82	0.32	-0.28	0.85
Net Tangible Assets	0.94	0.17	0.42	0.95		-0.97	0.03	0.95	0.96	0.76	0.6	0.19	0.2	0.52	0.35	0.87	0.1	0.96	0.96	0.15	0.38	0.44	0.81	0.41	-0.09	0.94
Net Debt	-0.96	-0.14	-0.37	-0.98	-0.97		-0.2	-0.97	-0.97	-0.7	-0.5	-0.11	-0.17	-0.44	-0.31	-0.77	0.02	-0.97	-0.88	-0.09	-0.24	-0.55	-0.85	-0.3	0.26	-0.92
Retained Earnings	0.04	-0.7	-0.68	0.27	0.03	-0.2		0.0	0.01	-0.53	-0.53	-0.74	-0.61	-0.73	-0.67	-0.37	-0.9	0.0	-0.23	-0.76	-0.8	-0.14	0.05	-0.59	-0.83	0.02
Cash	0.98	0.38	0.58	0.93	0.95	-0.97	0.0		1.0	0.84	0.63	0.28	0.41	0.63	0.54	0.85	0.23	1.0	0.93	0.33	0.42	0.68	0.92	0.48	-0.05	0.88
Cash And Short Term Investments	0.98	0.35	0.56	0.94	0.96	-0.97	0.01	1.0		0.83	0.62	0.27	0.38	0.62	0.51	0.84	0.2	1.0	0.93	0.31	0.4	0.66	0.91	0.46	-0.07	0.9
Net Receivables	0.77	0.69	0.86	0.61	0.76	-0.7	-0.53	0.84	0.83		0.75	0.71	0.66	0.93	0.81	0.85	0.66	0.84	0.87	0.69	0.75	0.68	0.75	0.68	0.37	0.75
Common Stock Total Equity	0.7	0.67	0.81	0.54	0.6	-0.5	-0.53	0.63	0.62	0.75		0.38	0.7	0.83	0.78	0.9	0.65	0.65	0.71	0.68	0.9	0.48	0.55	0.86	0.5	0.42
Common Stock Shares Outstanding	0.15	0.68	0.72	-0.04	0.19	-0.11	-0.74	0.28	0.27	0.71	0.38		0.57	0.79	0.69	0.33	0.74	0.27	0.34	0.74	0.69	0.41	0.26	0.5	0.53	0.29
Non Current Liabilities Total	0.4	0.99	0.92	0.15	0.2	-0.17	-0.61	0.41	0.38	0.66	0.7	0.57		0.81	0.96	0.52	0.88	0.41	0.38	0.96	0.72	0.7	0.55	0.82	0.7	0.04
Other Stockholder Equity	0.59	0.85	0.95	0.37	0.52	-0.44	-0.73	0.63	0.62	0.93	0.83	0.79	0.81		0.92	0.77	0.84	0.63	0.68	0.87	0.91	0.65	0.57	0.77	0.57	0.48
Total Liab	0.51	0.96	0.99	0.27	0.35	-0.31	-0.67	0.54	0.51	0.81	0.78	0.69	0.96	0.92		0.65	0.89	0.54	0.53	0.96	0.82	0.75	0.58	0.87	0.64	0.24
Net Invested Capital	0.88	0.49	0.71	0.78	0.87	-0.77	-0.37	0.85	0.84	0.85	0.9	0.33	0.52	0.77	0.65		0.49	0.86	0.94	0.48	0.74	0.48	0.71	0.74	0.3	0.74
Short Long Term Debt	0.18	0.92	0.87	-0.08	0.1	0.02	-0.9	0.23	0.2	0.66	0.65	0.74	0.88	0.84	0.89	0.49		0.22	0.35	0.95	0.81	0.43	0.29	0.77	0.88	0.02
Total Current Assets	0.98	0.37	0.58	0.94	0.96	-0.97	0.0	1.0	1.0	0.84	0.65	0.27	0.41	0.63	0.54	0.86	0.22		0.93	0.33	0.42	0.67	0.92	0.5	-0.04	0.88
Net Working Capital	0.91	0.37	0.59	0.85	0.96	-0.88	-0.23	0.93	0.93	0.87	0.71	0.34	0.38	0.68	0.53	0.94	0.35	0.93		0.35	0.55	0.47	0.8	0.57	0.16	0.89
Short Term Debt	0.3	0.99	0.93	0.04	0.15	-0.09	-0.76	0.33	0.31	0.69	0.68	0.74	0.96	0.87	0.96	0.48	0.95	0.33	0.35		0.81	0.61	0.44	0.77	0.77	0.04
Common Stock	0.43	0.75	0.86	0.23	0.38	-0.24	-0.8	0.42	0.4	0.75	0.9	0.69	0.72	0.91	0.82	0.74	0.81	0.42	0.55	0.81		0.38	0.32	0.83	0.67	0.29
Other Current Liab	0.64	0.67	0.75	0.5	0.44	-0.55	-0.14	0.68	0.66	0.68	0.48	0.41	0.7	0.65	0.75	0.48	0.43	0.67	0.47	0.61	0.38		0.68	0.52	0.0	0.4
Property Plant And Equipment Net	0.89	0.5	0.58	0.82	0.81	-0.85	0.05	0.92	0.91	0.75	0.55	0.26	0.55	0.57	0.58	0.71	0.29	0.92	0.8	0.44	0.32	0.68		0.49	0.1	0.68
Accounts Payable	0.53	0.77	0.87	0.32	0.41	-0.3	-0.59	0.48	0.46	0.68	0.86	0.5	0.82	0.77	0.87	0.74	0.77	0.5	0.57	0.77	0.83	0.52	0.49		0.62	0.23
Non Currrent Assets Other	-0.06	0.73	0.59	-0.28	-0.09	0.26	-0.83	-0.05	-0.07	0.37	0.5	0.53	0.7	0.57	0.64	0.3	0.88	-0.04	0.16	0.77	0.67	0.0	0.1	0.62		-0.22
Short Term Investments	0.83	0.05	0.33	0.85	0.94	-0.92	0.02	0.88	0.9	0.75	0.42	0.29	0.04	0.48	0.24	0.74	0.02	0.88	0.89	0.04	0.29	0.4	0.68	0.23	-0.22

Click cells to compare fundamentals

Renalytix Account Relationship Matchups

Renalytix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	41.3M	102.6M	63.3M	42.1M	8.0M	7.6M
Total Current Liabilities	3.4M	7.3M	12.2M	16.1M	11.5M	8.1M
Total Stockholder Equity	36.0M	95.1M	43.2M	18.5M	(7.9M)	(7.5M)
Net Tangible Assets	18.8M	71.5M	30.6M	7.0M	8.0M	7.6M
Net Debt	(12.7M)	(64.8M)	(28.6M)	(12.5M)	3.9M	4.0M
Retained Earnings	34.9M	3.8M	(53.0M)	(99.2M)	(211.8M)	(201.2M)
Cash	13.3M	65.2M	41.3M	24.7M	4.7M	4.4M
Non Current Assets Total	22.4M	26.6M	15.8M	13.8M	1.9M	1.8M
Cash And Short Term Investments	14.3M	74.5M	44.1M	26.1M	4.7M	4.4M
Net Receivables	18K	1.2M	901K	776K	722K	573.3K
Common Stock Shares Outstanding	29.5M	71.5M	73.8M	82.2M	108.2M	69.2M
Liabilities And Stockholders Equity	41.3M	102.6M	63.3M	42.1M	8.0M	7.6M
Non Current Liabilities Total	2.0M	213K	7.9M	7.5M	4.3M	3.6M
Other Stockholder Equity	2.8M	150.4M	164.0M	186.5M	204.9M	116.8M
Total Liab	5.3M	7.5M	20.1M	23.7M	15.8M	11.5M
Net Invested Capital	36.2M	71.5M	42.9M	30.4M	35.0M	38.4M
Short Long Term Debt	121K	53K	4.7M	4.5M	5.1M	5.4M
Total Current Assets	18.9M	76.0M	47.4M	28.3M	6.1M	5.8M
Net Working Capital	15.5M	59.7M	33.0M	12.2M	14.0M	23.7M
Common Stock	192K	233K	241K	299K	478K	265.2K
Other Current Liab	271K	4.1M	4.5M	8.6M	178K	169.1K
Property Plant And Equipment Net	945K	2.5M	3.1M	1.2M	216K	205.2K
Accounts Payable	2.9M	1.8M	2.5M	2.9M	2.6M	2.5M
Non Currrent Assets Other	83K	(1.1M)	1.5M	51K	1.6M	1.7M
Other Assets	2.4M	7.2M	1.2M	1.1M	1.3M	1.2M
Short Term Investments	982K	9.3M	2.7M	1.5M	1.7M	1.6M
Inventory	326K	353K	1.2M	718K	825.7K	562.5K
Other Current Assets	4.3M	1.2M	2.3M	1.4M	716K	1.3M
Property Plant And Equipment Gross	945K	2.7M	3.6M	1.2M	1.4M	1.9M
Accumulated Other Comprehensive Income	(1.9M)	8.3M	(915K)	(1.5M)	(1.4M)	(1.4M)
Capital Stock	192K	233K	228K	299K	343.9K	247.9K
Property Plant Equipment	945K	2.5M	2.6M	1.2M	1.4M	1.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Renalytix Other Stockholder Equity vs Cash And Short Term Investments Analysis

Other Stockholder Equity vs Cash And Short Term Investments

Other Stockholder Equity vs Cash And Short Term Investments Correlation Analysis

Correlation Coefficient

Other Stockholder Equity

Cash And Short Term Investments

Renalytix fundamental ratios Correlations

Renalytix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Renalytix fundamental ratios Accounts

Also Currently Popular

Additional Tools for Renalytix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Short Term Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Total Current Liabilities

Net Debt	- 0.98	Total Stockholder Equity
Total Current Assets	- 0.97	Net Debt
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.97	Net Tangible Assets
Net Debt	- 0.96	Total Assets